The International Society of Bone and Soft Tissue Pathology is inviting you to participate in the Annual Business Meeting (via Zoom).

Tuesday, March 16th, at 12:50 PM Eastern Time
Event Site: https://meetmsk.zoom.us/j/97098014475
Meeting ID: 970 9801 4475
Dial In: +1 646 876 9923

New Advances in Sarcoma Pathology & Therapy

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Tuesday, March 16, from 9:15 AM – 9:45 AM Pacific Time.

Recent advances in bone and soft tissue neoplasms are presented, specifically 1) primary vascular tumors of bone with molecular findings; 2) nerve sheath tumors including atypical entities and grading; 3) undifferentiated round cell sarcomas, now a family of different molecular entities; and 4) current sarcoma therapy which is becoming more diagnosis-specific.

Disclosures:
John S. Brooks: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the International Society of Bone & Soft Tissue Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Revisiting Old Challenges and Embracing New Paradigms 

This session includes 1.25 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Saturday, March 13, from 11:15 AM – 11:45 AM Pacific Time.

This symposium is designed to provide practicing pathologists and pathology trainees with an update on the most recent advances in breast pathology. Topics include the ongoing challenge of accurate diagnosis of intraductal papilloma on core biopsy and emerging evidence-based management strategies, assessment of immune cells in the tumor microenvironment, and genomic alterations that confer endocrine resistance in breast cancer. The chosen topics will be presented by expert faculty with diagnostic and research expertise in these areas.

Disclosures:
Fernando Schmitt: None
Hannah Y. Wen: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the International Society of Breast Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

A Novel Coronavirus Meets the Cardiovascular System: What We Know and How We Know It 

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Saturday, March 13, from 12:00 PM – 12:30 PM Pacific Time.

COVID-19 is an emerging, rapidly evolving situation. The effects of SARS-COV-2 virus on the cardiovascular system have been the subject of much reporting and speculation in the pathology literature and popular press. Trending in less than a year from obscurity to dominating the subject matter of manuscripts published rapidly in major journals; this has certainly been unprecedented. The findings observed range from myocarditis, Kawasaki-like disease, and disseminated microvascular thrombosis, but establishing which of these findings is truly specific to SARS-COV-2 virus related mechanisms is challenging and difficult to separate from those that may occur in any critically ill patient with systemic inflammatory response. This session will highlight the features of disease in the cardiovascular system for which there is growing consensus across emerging reports for SARS-COV-2 specificity. Tools for assessing accuracy and determining that specificity in new reports will be presented. The spectrum will encompass changes within the heart as well as other vascular beds. Radiologic-pathologic correlation of cardiovascular findings in COVID19 related patients will covered, including criteria helpful in gauging the specificity and sensitivity of imaging findings by various modalities. Research applications for tissue resources obtained from COVID-19 patient autopsy and other tissue specimens and integrating these activities with translational research programs will be modeled. Finally, potential endothelial mechanisms explaining the panoply of SARS-COV-2 related cardiovascular pathology will be explored.

Disclosures:
L. Maximilian Buja: None
James R. Stone: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Society for Cardiovascular Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cytological and Clinical Updates on HPV Vaccination and HPV Mediated Diseases of the Female Genitals, Anus, and Head & Neck

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Thursday, March 18th, from 1:00 PM – 1:30 PM Pacific Time. 

This course provides an update of current paradigms and the most recent literature in regard to HPV mediated diseases of the female genital tract, anus and head & neck. In addition, a clinical update on HPV vaccination will be provided. Each of four speakers will present for approximately 20 minutes.

Disclosure:
Charles D. Sturgis: None

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Making Cytology Global

This session includes 1 hour of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Tuesday, March 16, from 1:30 PM – 2:00 PM Pacific Time.

In this course it will be shown by Cytopathologists of different parts of the world, the importance in make cytology global. One of the ways is to classify the lesions using a standardized reporting system. It will be presented an international approach to the cytopathology of various body sites which will be link to the WHO Classification of Tumors series. The principles of Cancer Classification by Cytopathology will be presented as well as the importance of use a standardize nomenclature around the world. An example of the fundamental value of cytopathology in low/medium income countries will be demonstrated as well as the principles for the new four systems of classification using cytopathology: lung, lymph node, pancreas and soft tissue.

Disclosures:
Robert Y. Osamura: None
Fernando Schmitt: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the International Academy of Cytology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Current Challenges, Recent Developments and Future Directions for Cytopathology 

This session includes 1.25 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Sunday, March 14, from 1:30 PM – 2:00 PM Pacific Time.

This course will focus on current developments and challenges in cytopathology along with future developments for the improvements of the practice of cytopathology. The course will be constructed in three parts with the first presentation reviewing newer collection devices for cytology specimens. A number of new needle designs are currently offered for obtaining larger sample sizes by needle biopsy. These needles are used either in conjunction with or in place of standard needles currently used in fine-needle aspiration cytology at a variety of body sites. These newer needle designs are especially important for obtaining larger sample sizes during image guided procedures such as endobronchial biopsy of lung nodules or endoscopic biopsy of pancreatic or peripancreatic lesions. The design as well as advantages and disadvantages of these newer collection devices will be discussed.

The second presentation will focus on the cytologic diagnosis of infectious diseases. While cytology is often considered the optimal method for investigating neoplastic and pre-malignant lesions it can also serve as a rapid and accurate technique for the investigation of infectious diseases. Cytology is able to specifically identify a number of infectious agents including acid fast organisms, fungal organisms, bacteria and a number of viral diseases especially those involving the lung. This presentation will review optimal techniques for identifying infectious disease agents and summarize morphologic features associated with a wide variety of lesions including bacterial, fungal, AFB and viral induced diseases. Techniques for successful culture of organisms will be discussed. 

Artificial intelligence (AI) is becoming increasingly important for the practice of medicine. It offers major advantages to oncology with a potential for improved practice of personalized medicine. While AIs immediate impact may be most valuable in medical oncology the application of artificial intelligence may lead to improved diagnosis and classification of pathologic processes both in histopathology and cytology. The presentation will help define the concept of artificial intelligence, its current utilization and future directions with emphasis on its application in pathology. 

Disclosure: 
Lester J. Layfield: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Papanicolaou Society for Cytopathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Update in Dermatopathology

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Sunday, March 14th, from 3:00 PM – 3:30 PM Pacific Time.

The purpose of this topic is to underscore updates in select topics in dermatopathology. Cases that are illustrative of emerging entities/novel methodologies pertinent to the topic assigned will be discussed.

Disclosures:
Rajiv Patel: None

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Challenges in Neuroendocrine Neoplasms: What do pathologists need to know?

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Wednesday, March 17th, from 8:45 AM – 9:15 AM Pacific Time.

The 2021 USCAP Endocrine Pathology Society's Companion Meeting focuses on challenges in the diagnosis of neuroendocrine neoplasms (NENs). While most pathologists are familiar with NENs in the gut, pancreas, and lung, they are less aware of the spectrum of NENs in thyroid and parathyroid, pituitary and paraganglia (including adrenal medulla). The classification recently proposed by the WHO/IARC defines well differentiated epithelial NENs as neuroendocrine tumors (NETs) and poorly differentiated epithelial NENs as neuroendocrine carcinomas (NECs), providing a framework to understand the distinct molecular and pathogenetic features of these lesions, and further distinguishes mixed neuroendocrine and non-neuroendocrine neoplasms (MiNENs), and non-epithelial neuroendocrine neoplasms (paragangliomas and pheochromocytomas).This session will provide a diagnostic roadmap, addressing pitfalls and ancillary tools that are available, for the correct diagnosis, prediction and prognostication of the various NENs.

Disclosures:
Ozgur Mete: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Endocrine Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Rodger C. Haggitt Gastrointestinal Pathology Society (GIPS) is inviting you to participate in the Annual Business Meeting (via Zoom).
Monday  March 15, 2021. 5:00-5:30 PM PT
Event Site: HERE

Life Hacks

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Monday March 15, from 4:30 PM – 5:00 PM Pacific Time.

The Roger C. Haggitt GI Pathology Society invites you to an interactive session focusing on provocative issues in GI Pathology. In a world that is constantly changing and seemingly increasing in complexity a desire to simplify our lives is evident in many aspects of our daily life. Arguably pathology is not a simple discipline but there are certain shortcuts that experts in the field use to make their life simpler to arrive at meaningful diagnoses. Utilizing a new COVID-19 safe format this year’s session will tackle important issues and provide updates in the areas of molecular and inflammatory GI pathology, with a special memorial lecture focusing on first-hand experience of surviving in GI pathology for many decades. There will be ample time for discussion and questions by all learners!

The Stormy Monday Life Hack Blues: HERE
Music by TBONE WALKER
Lyrics by JOEL GREENSON

Disclosures:
David F. Schaeffer: Consultant, Alimentiv Inc.; Advisory Board Member, Satisfai Health Inc.; Consultant, Pfizer

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Rodger C. Haggitt Gastrointestinal Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Universal Cancer Screening: Preparing for Disruptive Innovation in Pathology Practice

This session includes 1 hour of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Tuesday, March 16th, from 2:15 PM - 2:45 PM Pacific Time. 

Blood samples that can be analyzed for the signatures of cancer at the molecular level are easily obtained from patients and multiple commercial firms are bundling signatures into panels of 20 to 50 + tumor types to create Universal Screening Tests. The sensitivity and specificity of these screens improves daily as well as the limit of detection which corresponds to Stage of cancer. In the very near future, a Universal Cancer Screening test(s) that detects signatures of a tumor before it is detectable by conventional means and long before it is symptomatic will be available. How will these tests be marketed? What role will surgeons, radiologists, pathologists, and oncologists play in such a paradigm? How will conventional screening programs that require pathologists be affected? With the advent of pan-tumor therapies, what role will specific diagnostics play if minimal signal can be treated with minimal therapy to eliminate a cancer before it is detectable by routine systems? This session will present the current state of these tests, the thinking in the field of how these tests can and will be implemented, and the scenarios around which such tests will bring about disruptive innovation and creative destruction to the entire landscape of modern oncopathology.

Disclosures
Dan Milner: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the ASCP. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The COVID-19 Autopsy Experience 

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Thursday, March 18th, from 11:30 AM – 12:00 PM Pacific Time.

The SARS-CoV2 virus which causes COVID-19 disease emerged from China in late 2019 and became a global pandemic in early 2020. The virus is highly infectious and produces high rates of mortality, especially among patients with co-morbidities (such as obesity, diabetes, heart disease, and others). Pathologists performing autopsies need to know what types of postmortem findings might be expected in patients with COVID-19 disease. Given the prevalence of the disease, many/most pathologists performing autopsies are likely to see some COVID-19 patients in the coming months and/or years. The expert speakers in this session will discuss and address the concerns surrounding the postmortem examination of COVID-19 decedents as well as the use of effective personal protective equipment while conducting these autopsies. In addition, the speakers will share their knowledge of the findings reported to date in decedents dying of or with COVID-19, including up-to-date information regarding the pathobiology of COVID-19 based on their personal experiences conducting autopsies on COVID-19 positive patients. They will review information from autopsy series starting to emerge from across the USA as well as other countries. The speakers will present the actual evidence that COVID-19 is a systemic viral disease with multifaceted abnormalities of the lungs, heart, and other organ systems.

Disclosures:
Chhavi Chauhan: None
William B. Coleman: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the American Society for Investigative Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Molecular Advances That Changed My Practice (and might change yours!)

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Wednesday, March 17th, from 11:15 AM – 11:45 AM Pacific Time.

The use of molecular characteristics to diagnose tumors in virtually every organ system has expanded exponentially over the past few years. However, many surgical pathologists are not comfortable incorporating these tests into their diagnostic routine and are not familiar with the variety of immunohistochemical and molecular tests that can aid in diagnosis and prognosis. The purpose of this course is to update practicing surgical pathologists and pathologists in training on various molecular advances in several organ systems, and to help them incorporate these tests into their practices.

Access The 2021 Arthur Purdy Stout Awards Page: Here

Disclosures:
Andrew L. Folpe: None
Laura W. Lamps: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Arthur Purdy Stout Society of Surgical Pathologists. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Molecular Pathology of Solid Tumors: China Experiences

This session includes 1 hour of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Saturday, March 13th, from 2:15 PM – 2:45 PM Pacific Time.

This is the Chinese Society of Pathology’s (CSPs) second official appearance at USCAP. It intends to use the event as a platform to bring China pathology experiences to the international stage. Prideful of a history of almost 100 years and over 20,000 members, CSP is the biggest official organization for Chinese pathologists and technicians. It plays an important role in promoting education and research, with multiple subdivisions covering every specialty from cytology, head and neck, GU, bone and soft tissue to molecular pathology. CSP has a dual commitment to bring in the state-of-art knowledge to Chinese pathologists as well as help them have a voice on the international stage.

Molecular pathology has had an increasing impact on pathological diagnosis and targeted therapy of solid tumors. In recent years, molecular diagnosis has been widely used in pathological practice and research in China. This program is intended to present some of the special advances in molecular pathology of solid tumors from China.

Disclosures:
Zhiyong Liang: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Chinese Society of Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Frontlines of the COVID-19 Pandemic

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Thursday, March 18th, from 9:45 AM – 10:15 AM Pacific Time.

The COVID-19 pandemic has disrupted our daily lives, forcing pathologists to refocus their current roles and adapt to the ever-changing landscape of this crisis. This session will focus on the frontlines of the COVID-19 pandemic from three pathologists experiences within the laboratory: pivoting the AP team to meet the greatest need, understanding the key pathologic features of acute infection and its long-term morbidity and mortality, and highlighting the disparities and outcomes of various racial groups with a historical perspective regarding treatment of minority communities in the medical setting. At the completion of this course, attendees will have increased their knowledge on managing the landscape of a pandemic through unique perspectives of leading pathologists in the frontlines of this pandemic. 

Disclosures:
Christina A. Arnold: None
Larissa V. Furtado: None

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Recent Advances and Updates in Histopathology

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Sunday, March 14, from 9:45 AM – 10:15 AM Pacific Time.

The virtual European Society of Pathology Companion Course will focus on new developments in histopathology of inflammatory bowel disease, lung cancer, vascular malformations and on recent updates in the lymphoma classification. 

The selected themes will be highlighted by expert faculty with diagnostic and research expertise in these areas. Recognition of the histological features and molecular basis of such anomalies and tumours are essential for characterizing and classifying such diseases, enhancing clinical management and alleviating the risk of diagnostic errors. The use of novel diagnostic approaches and integration of molecular procedures have a significant impact on identifying molecular predictive and prognostic markers and on selecting novel targeted molecular treatment. 

Disclosures:
Holger Moch: None
Ales Ryska: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the European Society of Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Genitourinary Pathology Society (GUPS) is inviting you to participate in the Annual General Meeting (via Zoom).
Date: March 18, Thursday;   Start time: 10:15AM (Pacific Time)

Join Zoom Meeting:
https://albertahealthservices.zoom.us/j/96828230158?pwd=WHVJK0luK2g5V2R3Y3NPWlVQN1Vwdz09

Meeting ID: 968 2823 0158
Passcode: 685515

Digital Pathology and Artificial Intelligence in Genitourinary Pathology: Present and Future Perspective 

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Thursday, March 18, from 9:45 AM – 10:15 AM Pacific Time.

This course is dedicated to virtual pathology. The first presentations will aim where we stand and what is possible at the very moment, the second part is in order to show what will be possible and in which direction further numeric pathology will develop. This course is especially important in times of COVID-19 or any pandemic, where people have to work from home and are unable to join the lab.

Disclosures:
Daniel Berney: None
Eva M. Comperat: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Genitourinary Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Challenging Topics in Bladder Tumour Pathology

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Sunday, March 14, from 3:00 PM – 3:30 PM Pacific Time.

Bladder cancer is extraordinarily diverse in histomorphology and molecular features. In morphology, this diversity is manifest as variant histology, named histologic patterns with unique clinical ramifications. In molecular alterations, diversity is seen in expression subtypes and somatic mutations, among many other features, as dramatically shown in the initial TCGA bladder publication in 2014. Soft tissue tumors of the bladder are rare, and often challenging to classify. It is important for surgical pathologists to understand the criteria for diagnosing variant histology and soft tissue tumor of the bladder, and the clinical consequences of these diagnoses. The 2021 ISUP Companion Society Meeting will focus on variant histology of bladder cancer and rare but important soft tissue tumors of the bladder. There will be three, 30-minute lectures delivered by surgical pathologists with a live 30-minute question and answer session.

Disclosures: 
Michelle R. Downes: None
Joshua Warrick: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the International Society of Urological Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The International Society of Gynecological Pathologists is inviting you to participate in their Annual Business Meeting and Social Event (via Zoom).

International Society of Gynecological Pathologists Annual Business Meeting
Sunday March 14, 2021. 3:30-4:00 pm EST

Registration: https://us02web.zoom.us/webinar/register/WN_CRP-h5uuRNWGCkvCFoVlww 

International Society of Gynecological Pathologists Social Event
Sunday March 14, 2021. 4:00-5:00 pm EST

Event site: www.kumospace.com/isgyp2021

Practical Updates from the new 5th edition WHO Classification System of Tumors of the Female Genital Tract 

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Sunday, March 14, from 12:00 PM – 12:30 PM Pacific Time.

This session will summarize practical updates from the newly published 5th edition of the World Health Organization classification of tumors of the female genital tract (the WHO "blue book").  The presenters in the session are the main editors of the new "blue book".  The major topics are endocervical adenocarcinoma classification, reporting and staging, mesenchymal tumor diagnosis, endometrial cancer classification, vulvar squamous cell carcinoma classification, and updates in gestational trophoblastic disease and hereditary tumor syndromes.  The sessions will be succinct summaries designed to guide pathologists in understanding the key updates in the new WHO classification that will be most relevant to daily diagnostic practice.

Disclosures

Joseph Rabban: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the International Society of Gynecological Pathologists. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The North American Society of Head and Neck Pathology (NASHNP) is inviting you to participate in the Annual Business Meeting (via Zoom).
Wednesday, March 17, 2021. 12:45-1:45 PM PT
Event Site: https://uchicagomedicine.zoom.us/j/95279787544?pwd=WkM3cDQxNEJLZHg1SEs2ejZWek5KUT09

Beware! Mistakes and Mistake-Prone Areas in Head and Neck Pathology (and How to Avoid Them) 

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Wednesday, March 17, from 11:15 AM – 11:45 AM Pacific Time.

Experienced head and neck pathologists are used to seeing the most complex and challenging cases. Working in large referral centers, they are constantly reviewing outside pathology when patients come for treatment to their institutions. This means seeing a lot of diagnostic mistakes others make. With more than 80 years of practical experience in academic head and neck pathology to draw from, and from their own consultative practices, the presenters in this course will share case examples of some of the most common and important mistakes or mistake-prone scenarios in sinonasal, oral cavity, laryngeal, and neck pathology with review of the actual digital slides in real time, a thorough discussion of the salient diagnostic features, and tips on how to avoid making mistakes when you are confronted with them. There will also be a 30-minute live Q&A session with questions posed by the attendees discussed by the four presenters.

Disclosures:
Sandra I. Camelo-Piragua: None
Charles G. Eberhart: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the North American Society for Head and Neck Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Clonal Hematopoiesis

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Monday, March 15, from 12:00 PM – 12:30 PM Pacific Time.

This course will provide an overview of the recent advances in the area of clonal hematopoiesis. Topics will include the initial characterization of clonal hematopoiesis of indeterminate potential or age related clonal hematopoiesis (CHIP or ARCH) and its clinical associations, the mutational landscape and clonal architecture of myeloid disorders including CHIP/ARCH and clonal cytopenia of undetermined significance (CCUS), inherited myeloid disorders, and the effect of clonal hematopoiesis on molecular measurable residual disease (MRD) assays.

Disclosures:
Eric J. Duncavage: Consultant, Cofactor Genomics; Consultant, Genescopy; Stock Ownership, P&V Licensing
Tracy I. George: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Society for Hematopathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Health Institutions: Past, Present and Future

This session includes 1.25 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Thursday, March 18, from 9:00 AM – 9:30 AM Pacific Time.

Public institutions that document, preserve and teach about the history of medicine - including pathology - are an important part of our professional and general cultural heritage. The 2021 History of Pathology Society meeting will focus on three such American institutions: The Centers for Disease Control and Prevention and its David J. Sencer Museum, the National Library of Medicine of the National Institutes of Health, and the Joint Pathology Center. Speakers will discuss the origins and development of their respective institution and will provide information about current and potential future projects.

Disclosures:
Richard Fraser: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the History of Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

What Pathologists Need to Know About COVID-19: Histopathology, Testing, Genomic Surveillance of SARS-CoV-2 Variants, Mass Fatality Planning and Autopsy Findings 

This session includes 1 hour of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Sunday, March 14th, from 12:45 PM – 1:15 PM Pacific Time.

The topic of this year’s meeting is COVID-19. Speakers are invited to present on their recent work on COVID. We are currently planning on including a variety of speakers with expertise in range of topics including histopathology, tissue-based testing, clinical laboratory testing, and biosafety concerns relevant to pathologists.

Disclosures:
Dianna Ng: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Binford-Dammin Society of Infectious Disease Pathologists. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Emergence of Artificial Intelligence and Applications to Digital Pathology and Whole Slide Imaging: Lessons Learned from Yearly API Workshops.

This session will address the emerging technologies and worklow process necessary to bring digital pathology and artificial interlligence to fruition in the diagnostic laboratory. Four the last five years the API has offered both workshops and more recently multi-day conferences addressing this topic. The course will provide both an overview of lessons learned in those sessions, as well as presentations from key leaders and contributors. This session will address the emerging technologies and work low process necessary to bring digital pathology and artificial intelligence to fruition in the diagnostic laboratory. For the last five years, the API has offered both workshops and multi-day conferences addressing this topic. The companion society course will provide both an overview of lessons learned in those prior sessions, as well as presentations from key leaders and contributors. A detailed understanding of the technology as well as practical tips for successful use and implementation will be shared from the re-world perspective of these pioneers in the field.

Disclosures:
J. Mark Tuthill: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Association for Molecular Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Diagnostic Dilemmas in Liver Pathology

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Thursday, March 18, from 1:00 PM – 1:30 PM Pacific Time.

Common diagnoses in liver pathology are usually routine to most liver pathologists. However, challenging cases are frequently lurking within our work loads. Being fascile with subtle histopathologic findings and recognition of vague or understated clinical and laboratory information can allow for timely and accurate diagnoses of even the most difficult cases. The Hans Popper Companion Session will cover a range of difficult scenarios including the nearly normal liver biopsy, distinguishing liver graft-versus-host disease from mimics, and recognizing that not all steatohepatitis cases, even in obese patients, are simply "NASH".

In the setting of the nearly normal liver biopsy, Dr Taofic Mounajjed from the Mayo Clinic will provide guidance on subtle but critical diagnoses we should never miss. As bone marrow and stem cell transplantation become more common, caring for these patients becomes more frequent. Dr Isabel Fiel from Mount Sinai School of Medicine will empower us to use her novel diagnostic algorithm for ruling in or ruling out liver graft-versus-host disease in a decisive and timely manner. It is very likely that nonalcoholic steatohepatitis (NASH) represents a huge volume of our typical liver pathology practices, however, there are many important mimics that we must all be vigilant to recognize and diagnose correctly. Dr David Kleiner of the NIH will help us expand our steatohepatitis differential diagnoses and provide confidence for knowing when a steatohepatitis case represents something other than routine NASH.

Disclosures:
Cynthia Guy: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Hans Popper Hepatopathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Searching for COVID-19

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Wednesday, March 17, from 3:15 PM – 3:45 PM Pacific Time.

Acute kidney injury can be a frequent and serious complication in patients infected by COVID-19 coronavirus, a variety of pathologic injuries have been reported in the kidneys of COVID-19 positive subjects, and the pathophysiological mechanisms remain unclear.

The course will provide an overview of the renal pathologic lesions observed in the setting of COVID-19 infection, a discussion of ultrastructural features of Coronaviruses and the diagnostic use of electron microscopy on tissue from COVID-19 infected patients, and an update on clinical testing for detection of COVID-19 infection. 

Disclosure: 
Serena M. Bagnasco: None
Giovanna M. Crisi: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Renal Pathology Society & Society for Ultrastructural Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Utilization of Cell free DNA (cfDNA) in Oncology

This session includes 1.25 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Sunday, March 14th, from 10:30 AM – 11:00 AM Pacific Time.

Cell free DNA (cfDNA) testing represents a clinically important new frontier in biomarker testing for cancer patients.  These series of talks will address the basic technical concepts regarding cf, and the challenges this approach presents in practice for both the diagnostician and the treating physician. Additional there will be further emphasis on new advances in utility of cfDNA in lung cancer, the sources of biological signal in circulating tumor DNA analysis, and clinical sequencing of cell-free DNA from CSF in brain tumor patients.

Disclosures:
Amir Behdad: Speaker, Bayer; Speaker, Foundation Medicine China; Speaker, Thermo Flsher Scientific

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Association for Molecular Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Extra-axial Neoplasms and Neuropathology Practice Patterns

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1, 2021. There will also be a live 30-minute Q&A session with the faculty on Saturday, March 13th, from 12:45 PM – 1:15 PM Pacific Time.

As our understanding of the biology and molecular alterations involved in the tumorigenesis of various lesions grows, frequent updates are made to the nomenclature and classification of these disease processes. This year's AANP Companion Meeting will focus on extra-axial neoplasms of the nervous system, to include dural-based tumors and peripheral nerve sheath tumors. Updates to these tumor types will be reviewed from a practical diagnostic perspective to familiarize participants with emerging diagnostic tools, potential diagnostic pitfalls, and implications of the new classification and tumor grading. These topics have practical implications for the diagnosticians who see both neuropathology and general surgical pathology in their practice. In concert with this traditional theme-based approach for a more focused discussion, a talk on Neuropathology Practice Patterns will be included to provide insights on neuropathology as a subspecialty, mainly targeting general pathology and neuropathology trainees. The overarching goals are to tackle some of the potential current and future challenges that the general practitioners and those who practice in small academic institutions face relative to the above topics, and that are not necessarily specifically covered in the context of other Short Courses, while also providing insights into the various aspects of neuropathology practice. It is hoped that participation in discussions from pathologists in various practice settings will add to the content especially in regard to integration of computerized systems and handling of the molecular component of the integrated diagnostic approach.

Disclosure:
Sandra I. Camelo-Piragua: None
Charles G. Eberhart: None

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Ocular Pathology: Current Guidelines and Approaches

This session includes 1.25 hours of on-demand educational content. This content can be viewed starting March 1, 2021. There will also be a live 30-minute Q&A session with the faculty on Monday, March 15th, from 11:15 AM – 11:45 AM Pacific Time.

The American Association of Ocular Oncologists and Pathologists aims to emphasize the importance of ocular pathology, particularly as a complex area of practice that requires a broad range of expertise. The program of "Ocular Pathology: Current Guidelines and Approaches” is focused on reviewing practical diagnostic topics encountered by ocular pathologists in clinical practice. Ocular pathology can be a challenging discipline for the practicing surgical pathologist, and therefore topics presented during this session will cover some of the more difficult diagnoses, which include lacrimal gland tumors, temporal arteritis, syndromic diseases, and ocular surface melanocytic lesions.

Disclosure
Thomas J. Cummings: None
Vivian Lee: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and American Association of Ophthalmic Oncologists and Pathologists. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Paleopathology Around the Globe

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1, 2021. The Paleopathology Club will not hold a live Q&A session. All questions will be dirctly sent by email by the attendees to the speakers for individual follow-up. 

Summary of Program:
This Symposium will review archaeological excavations of human remains from different geographic areas. Paleopathological findings include a variety of lesions and genetic information which can help to evaluate the prevalence of diseases in ancient times or to obtain important anthropological information which can be compared with modern populations.

About the Club: 
Welcome to the Scientific Virtual Meeting of the Paleopathology Club. The Club is 49 years old, we have about 500 members around the globe and we communicate with a Newsletter by e-mail twice a year with news about Paleopathology. If you want to become a member, please send us your email, name, address and affiliation. You will become a member and there is no charge or fee. The Club is supported by the Department of Pathology of the Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia.

For More Information About the Paleopathology Club Contact:
Pedro L. Fernandez, MD, PhD; Universidad Autonoma de Barcelona, Spain at plfernandez.germanstrias@gencat.cat  
Enrique Gerszten, MD; Virginia Commonwealth University, Richmond, VA at enrique.gerszten@vcuhealth.org  

Disclosures:
Pedro L. Fernandez: None
Enrique Gerszten: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Paleopathology Club. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Inflammatory Conditions of the Pancreatobiliary Tree 

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Tuesday, March 16, from 11:00 AM – 11:30 AM Pacific Time.

Chronic pancreatitis is a complex inflammatory process with rising incidence and prevalence, and no curative treatment for frequently intractable chronic pain. Despite advances in the field, challenges remain in the radiologic, endoscopic and histologic diagnosis, and the distinction of pancreatitis from cancer. Although some specific pathologic subtypes of pancreatitis have been described and characterized in the past decade, many pathologists are still unaware of their existence, clinicopathologic characteristics, management and genetic implications. Pathologists also struggle with formulating diagnoses, reporting terminology, and determining etiology, particularly on small biopsies, fine needle aspirations and bile duct brushings. In the past year alone numerous multidisciplinary international, consensus guideline manuscripts have made new recommendations regarding risk factors, etiology, management (endoscopic, surgical/non-surgical), and histopathology of chronic pancreatitis. The latter was aimed at clarifying the pathologist’s role in diagnosis, histopathologic criteria, standardizing reports, and limiting confusion in reporting and the literature. The Pancreatobiliary Pathology Society executive committee determined the theme, titles, content and speakers for this year's companion meeting, with a mission to educate surgical and Cytopathologists on recent advances in inflammatory conditions of the pancreatobiliary tree. This year’s meeting will provide a 360-degree expert analysis and update on acute and chronic inflammatory conditions of pancreatobiliary tree, including specific entities acute/alcoholic pancreatitis (Dr. Günter Klöppel), paraduodenal pancreatitis (Dr. Giuseppe Zamboni), IgG4-related (autoimmune) pancreatitis (Dr. Vikram Deshpande), and the cytopathology of inflammatory lesions of the pancreatobiliary tree(Dr. Barbara Centeno).

Disclosure:
Rondell Graham: None
Michelle D. Reid: None

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Pancreatobiliary Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hot Topics in Lung Pathology

This session includes 1.5 hours of on-demand educational content. This content can be viewed starting March 1. There will also be a live 30-minute Q&A session with the faculty on Tuesday, March 16, from 1:30 PM – 2:00 PM Pacific Time.

This session will provide updates on the latest "hot" topics in lung pathology including the pathology of COVID-19 lung infection, updates on the new WHO classification of thoracic tumors, and pathological assessment of resected lung cancers following neoadjuvant chemotherapy.

Disclosures:
Wendy Cooper: None
Lida P. Hariri: None
 

Continuing Medical Education

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and the Pulmonary Pathology Society. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this Other activity (enduring materials and internet live activity) for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.